PFO
KDNY

Pathstone Family Office’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Pathstone Family Office’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6
Closed – – 675
2017
Q1 		$0 Buy
+6
New – ﹤0.01% 638